Corporate Governance

Arun Kumar is a first-generation entrepreneur and known for his ability to identify great opportunities in “difficult to operate” business domains. He founded Strides Pharma Science Limited (Strides) in 1990 and has since then led the company in building a global reputation with a differentiated business model and delivering value for its stakeholders (over $5B value creation for shareholders, including distribution of the most extensive dividend by a pharmaceutical company in India).

Besides founding Strides, Arun’s family office (setup in the early 2000s) ran a differentiated set of investments spread across several companies with a combined revenue base of over a billion dollars and an invested capital of over half a billion dollars. Arun is credited to have co-founded and built India’s largest fully integrated Animal Health Company, SeQuent Scientific Limited, in less than five years. Arun’s stake in SeQuent was divested to the Carlyle Group in May 2020.

Arun is the promoter of Solara Active Pharma Sciences, a pure-play API company, targeted to become India’s second-largest API business in less than four years. Recently, Arun’s family office has entered a strategic partnership with marquee investors to build a global biologics CDMO, specialty injectable and vaccine business with capabilities across several technology platforms. The businesses run under Arun’s leadership and ownership have presence in 100+ countries with 7000+ employees and over 25 global manufacturing facilities worldwide.

Arun is a recipient of “EY Entrepreneur Of The Year Award” in the healthcare sector in 2000, Business Today “India Best CEO Award” (in mid-sized companies category), and “The Best CEO in the Pharma & Healthcare Industry” in 2014.